Pick a prescription medication we may have studied this trimester that you will encounter in your future practice as an APRN and discuss the following information in a voice-over PowerPoint or Kaltura presentation. The medication needs to be a prescription medication that has a use for a condition you will manage in your future APRN practice.
Please note that use of AI is prohibited on this assignment. If AI use is suspected, student will receive a zero on this assignment and be reported to the Office of Academic Integrity. Use of your or another student’s previous presentation constitutes plagiarism/cheating and will be handled in the same manner. Presentations will be put through TurnItIn for faculty review.
Presentation Outline: Metformin (Glucophage)
Voice-Over PowerPoint or Kaltura Presentation
Slide 1: Title Slide
Title: Metformin (Glucophage): A Cornerstone in Type 2 Diabetes Management
Subtitle: Essential Information for Advanced Practice Registered Nurses (APRNs)
Your Name, Program, Date
Slide 2: Introduction
Key Points:
- Metformin is a first-line oral antihyperglycemic medication for managing Type 2 Diabetes Mellitus (T2DM).
- Widely prescribed due to its efficacy, safety profile, and cost-effectiveness.
- As an APRN, you will encounter patients with T2DM, making Metformin a critical medication in your practice.
Slide 3: Mechanism of Action
Key Points:
- Class: Biguanide
- Primary Actions:
- Decreases hepatic glucose production (gluconeogenesis).
- Increases insulin sensitivity in peripheral tissues (muscle and fat).
- Enhances glucose uptake and utilization.
- Does not stimulate insulin secretion, minimizing the risk of hypoglycemia.
Slide 4: Indications
Key Points:
- Primary Use: Management of Type 2 Diabetes Mellitus (monotherapy or in combination with other agents).
- Off-Label Uses:
- Polycystic Ovary Syndrome (PCOS) to improve insulin resistance and regulate menstrual cycles.
- Prediabetes to delay progression to T2DM.
- Weight management in patients with obesity and insulin resistance.
Slide 5: Dosage and Administration
Key Points:
- Initial Dose: 500 mg orally once or twice daily, or 850 mg once daily.
- Maintenance Dose: Gradually increase to 2000 mg/day (maximum dose) based on tolerance and glycemic control.
- Extended-Release Formulation: Available for patients with gastrointestinal (GI) intolerance.
- Administration Tips:
- Take with meals to reduce GI side effects.
- Avoid in patients with severe renal impairment (eGFR < 30 mL/min).
Slide 6: Side Effects
Key Points:
- Common Side Effects:
- Gastrointestinal: Nausea, diarrhea, abdominal discomfort (usually transient).
- Metallic taste.
- Rare but Serious Side Effects:
- Lactic acidosis (rare but life-threatening; monitor in high-risk patients).
- Vitamin B12 deficiency with long-term use (monitor levels periodically).
Slide 7: Contraindications and Precautions
Key Points:
- Contraindications:
- Severe renal impairment (eGFR < 30 mL/min).
- Metabolic acidosis (e.g., diabetic ketoacidosis).
- Hypersensitivity to Metformin.
- Precautions:
- Use cautiously in elderly patients and those with hepatic impairment.
- Temporarily discontinue before iodinated contrast imaging to reduce the risk of contrast-induced nephropathy.
Slide 8: Monitoring and Patient Education
Key Points:
- Monitoring:
- Hemoglobin A1C (every 3-6 months).
- Renal function (eGFR at baseline and annually).
- Vitamin B12 levels in long-term users.
- Patient Education:
- Take with meals to minimize GI side effects.
- Report symptoms of lactic acidosis (e.g., muscle pain, weakness, difficulty breathing).
- Avoid excessive alcohol consumption to reduce the risk of lactic acidosis.
Slide 9: Clinical Pearls for APRNs
Key Points:
- Metformin is first-line therapy for T2DM due to its efficacy, safety, and low cost.
- Start low and titrate slowly to minimize GI side effects.
- Monitor renal function and educate patients about the signs of lactic acidosis.
- Consider extended-release formulations for patients with GI intolerance.
Slide 10: Conclusion
Key Points:
- Metformin is a cornerstone medication for managing Type 2 Diabetes Mellitus and other insulin-resistant conditions.
- As an APRN, understanding its mechanism, indications, side effects, and monitoring requirements is essential for safe and effective patient care.
- Patient education and regular monitoring are key to optimizing outcomes with Metformin therapy.
Slide 11: References
Key Points:
- Include peer-reviewed articles, clinical guidelines (e.g., ADA Standards of Care), and drug prescribing information.
- Examples:
- American Diabetes Association. (2023). Standards of Medical Care in Diabetes.
- Lexicomp. (2023). Metformin: Drug Information.
- UpToDate. (2023). Metformin: Pharmacology and Use in Diabetes.
This presentation provides a comprehensive overview of Metformin, tailored to the needs of an APRN managing patients with Type 2 Diabetes Mellitus. Let me know if you’d like to expand on any section or add visuals!